Exceptions or additions to the recognized standards

 

Minimum Inhibitory Concentrations
(mcg/mL)

Disk Diffusion
(zone diameters in mm)

Pathogen

S

I

R

S

I

R

Candida albicans

≤0.12

≥13

Candida glabrata

≤0.12

≥ 15

Candida parapsilosis

M27M44S supplement is recognized

≥9

Candida tropicalis

≤0.12

≥ 14

S = Susceptible; I = Intermediate; R = Resistant
For the species listed below, susceptibility test interpretive criteria included in M27M44S supplement are not recognized:
Candida auris
Candida dubliniensis
Candida krusei

  • Content current as of:

    10/16/2025

Source

Clinical :: Oncology :: Nuclear :: Geriatric :: Regulatory :: Technology :: Consulting

"My passion is helping businesses, small and large, perform at their best." - Felicia Udoji-Eddings, Pharm.D.

Dr. Felicia Udoji-Eddings is the Founder and CEO of The Health Pals Company, a vertically integrated Healthcare System. As an experienced Clinical Pharmacy Leader, Pharmacy Consultant, Healthcare Executive, and Licensed Pharmacy Practitioner with deep backgrounds in Information Technology (IT), Scientific Research, and Business Management. Dr. Udoji-Eddings has a strong track record of exceptional performance in different business environments. A skilled Business Strategist, Dr. Udoji-Eddings has tackled complex problems and helped several organizations refocus their strategy in tough economic times. As a highly motivated and proactive individual, Felicia enjoys working with teams, in various capacities, to facilitate positive outcomes.